IL109037A - תכשירים לגרימת הפרדת פזות של שכבות ליפידיות והכנת התכשירים הנ" ל - Google Patents

תכשירים לגרימת הפרדת פזות של שכבות ליפידיות והכנת התכשירים הנ" ל

Info

Publication number
IL109037A
IL109037A IL10903794A IL10903794A IL109037A IL 109037 A IL109037 A IL 109037A IL 10903794 A IL10903794 A IL 10903794A IL 10903794 A IL10903794 A IL 10903794A IL 109037 A IL109037 A IL 109037A
Authority
IL
Israel
Prior art keywords
composition according
group
epithelial
cholesterol
composition
Prior art date
Application number
IL10903794A
Other languages
English (en)
Other versions
IL109037A0 (en
Original Assignee
Cellegy Pharma Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellegy Pharma Inc, Univ California filed Critical Cellegy Pharma Inc
Publication of IL109037A0 publication Critical patent/IL109037A0/xx
Publication of IL109037A publication Critical patent/IL109037A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
IL10903794A 1993-03-19 1994-03-18 תכשירים לגרימת הפרדת פזות של שכבות ליפידיות והכנת התכשירים הנ" ל IL109037A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3380793A 1993-03-19 1993-03-19

Publications (2)

Publication Number Publication Date
IL109037A0 IL109037A0 (en) 1994-06-24
IL109037A true IL109037A (he) 1999-01-26

Family

ID=21872550

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10903794A IL109037A (he) 1993-03-19 1994-03-18 תכשירים לגרימת הפרדת פזות של שכבות ליפידיות והכנת התכשירים הנ" ל

Country Status (3)

Country Link
AU (1) AU6589494A (he)
IL (1) IL109037A (he)
WO (1) WO1994021230A1 (he)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190894B1 (en) 1993-03-19 2001-02-20 The Regents Of The University Of California Method and compositions for disrupting the epithelial barrier function
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
US5863716A (en) * 1994-09-19 1999-01-26 The Leland Stanford Junior University Board Of Trustees Treatment of plasmodium
JPH10506531A (ja) * 1994-09-19 1998-06-30 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー マラリア病の治療
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
WO1998017253A1 (en) * 1996-10-23 1998-04-30 The Regents Of The University Of California Method and compositions for disrupting the epithelial barrier function
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
USRE37770E1 (en) 1997-01-24 2002-06-25 The Regents Of The University Of California Treatment of skin conditions by use of PPARα activators
US6060515A (en) * 1997-01-24 2000-05-09 The Regents Of The University Of California Treatment of skin conditions by use of PPARα activators
US6060043A (en) * 1998-02-03 2000-05-09 The Gillette Company Deodorant composition containing D-amino acid
WO2000066105A2 (en) * 1999-04-30 2000-11-09 The Trustees Of Boston College Treatment of epilepsy with imino sugars
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
KR100764699B1 (ko) * 2000-09-08 2007-10-08 알자 코포레이션 경로 폐쇄 저해에 의한 경피 약물 플럭스 감소 저해방법
DE10214506A1 (de) * 2002-04-02 2003-10-16 Beiersdorf Ag Verwendung von Desoxynojirimycin und dessen Derivaten zur Behandlung und Prophylaxe degenerativer Hautzustände

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
US5073372A (en) * 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5215759A (en) * 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition

Also Published As

Publication number Publication date
IL109037A0 (en) 1994-06-24
WO1994021230A1 (en) 1994-09-29
AU6589494A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
US5885565A (en) Methods for inducing phase separation of epithelial lipid bilayers
US6562606B1 (en) Methods and compositions for disrupting the epithelial barrier function
AU759326B2 (en) Skin penetration enhancing components
EP1079804B1 (en) Pharmaceutical compositions comprising an amphoteric surfactant an polypropoxylated cetyl alcohol and a polar drug
JP2953625B2 (ja) 薬剤／浸透促進組成物に関連する皮膚刺激を低下させる方法
Ali et al. The structure of skin and transdermal drug delivery system-a review
IL109037A (he) תכשירים לגרימת הפרדת פזות של שכבות ליפידיות והכנת התכשירים הנ" ל
US6727401B1 (en) Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
BR9814014B1 (pt) Composição para aplicação tópica tendo propriedades de melhora da penetração
EP0216303B1 (en) External medication
US20110263715A1 (en) Local Anesthetic Emulsion Compositions and Methods of Making and Using the Same
WO1994021271A1 (en) Methods and compositions for inducing phase separation of epithelial lipid bilayers
AU2021206858B2 (en) Isotretinoin formulations and uses and methods thereof
US11878008B2 (en) Composition for preventing or treating atopic dermatitis
EP0693932A1 (en) Methods and compositions for inducing phase separation of epithelial lipid bilayers
WO1998017253A1 (en) Method and compositions for disrupting the epithelial barrier function
Mills et al. Effect of solute lipophilicity on penetration through canine skin
JPH06256182A (ja) 外用製剤
AU2003211175B2 (en) Skin penetration enhancing components
Balasubramaniyam et al. Development of Ethosomal Gel Loaded with Terminalia chebula for Effective Treatment of Arthritis
CN116096358A (zh) 一种ak3287制剂及其制备方法和应用
US20170196980A1 (en) Transdermal enhancer
TW397688B (en) Compositions effective in enhancing the qualities of skin and comprising macrocyclic ester, diester, ketone or lactone as an active ingredient
Loveridge Novel pour-on technology in cattle: a thesis presented in partial fulfilment of the requirements for the degree of Master of Philosophy in Veterinary Clinical Science at Massey University
Fincher The effect of skin penetration enhancers on the permeation of dideoxynucleoside anti-HIV drugs in vitro and in vivo

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed